Form 4: Wellington Biomedical Innovation Master Investors Reports Conversion of Preferred Stock to Common Stock in Upstream Bio, Inc.

Wellington Biomedical Innovation Master Investors reports the conversion of Series B redeemable convertible preferred stock into common stock of Upstream Bio, Inc. following the company's IPO.

Summary

• On October 15, 2024, Wellington Biomedical Innovation Master Investors (Cayman) II L.P. reported a transaction involving Upstream Bio, Inc. [UPB].
• The transaction involved the conversion of 852,940 shares of Series B redeemable convertible preferred stock into 894,733 shares of common stock.
• The conversion occurred automatically upon the closing of Upstream Bio's initial public offering (IPO) at a ratio of 1.049 common shares for each preferred share.
• The reporting entity maintains direct ownership of the 894,733 shares of common stock following the conversion.

Sentiment

Score: 7

Explanation: The document reflects a neutral to slightly positive sentiment. The conversion of preferred stock to common stock after an IPO is a standard and generally positive event, indicating the company has reached a significant milestone.

Positives

• The conversion of preferred stock to common stock typically signals increased confidence in the company's future prospects following its IPO.

Future Outlook

The document does not contain specific forward-looking statements beyond the reporting of the conversion event.

Industry Context

This Form 4 filing is a routine disclosure following a corporate event (the IPO) that triggers a change in beneficial ownership. It's common for preferred stock to convert to common stock upon an IPO.

Comparison to Industry Standards

• The conversion of preferred stock to common stock upon an IPO is a standard practice in the venture capital and biotech industries.
• Similar conversions occur in companies like Moderna and BioNTech after their IPOs, where early investors' preferred shares converted to common shares, reflecting the increased valuation and liquidity following the public offering.

Stakeholder Impact

• The conversion of preferred stock to common stock may dilute existing shareholders to a small degree.
• The conversion provides liquidity to the holders of the preferred stock.

Key Dates